Zhengyin Liu Selected Research

Zhengyin Liu Research Topics

Disease

14	COVID-19 01/2024 - 01/2020
8	Infections 08/2023 - 07/2011
6	Critical Illness (Critically Ill) 08/2023 - 01/2020
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2024 - 12/2020
2	Candidemia 08/2022 - 02/2019
2	Inflammation (Inflammations) 02/2021 - 01/2020
2	Healthcare-Associated Pneumonia 01/2016 - 01/2015
1	Vasculitis (Vasculitides) 01/2024
1	Pneumonia (Pneumonitis) 08/2023
1	Communicable Diseases (Infectious Diseases) 08/2023
1	Pneumococcal Infections 01/2022
1	Respiratory Sounds (Crackle) 01/2022
1	Wounds and Injuries (Trauma) 02/2021
1	Pressure Ulcer (Bedsore) 02/2021
1	Lymphopenia (Lymphocytopenia) 02/2021
1	Neoplasms (Cancer) 01/2021
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Meningitis 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Coinfection 12/2020
1	Cerebral Infarction 10/2020
1	Stroke (Strokes) 01/2020
1	Ischemic Stroke 01/2020
1	Cytokine Release Syndrome 01/2020
1	Persistent Infection 03/2019
1	Fungemia 02/2019
1	Gram-Positive Bacterial Infections 06/2015
1	Chronic Hepatitis B 09/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 08/2002
1	Cryptococcal Meningitis 08/2002

Drug/Important Bio-Agent (IBA)

5	Antiphospholipid AntibodiesIBA 01/2024 - 01/2020
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 08/2002
3	Carbapenems (Carbapenem Antibiotics)IBA 08/2023 - 01/2022
3	AntibodiesIBA 01/2021 - 10/2020
2	EchinocandinsIBA 08/2022 - 02/2019
2	Penicillins (Penicillin)FDA Link 01/2022 - 01/2021
2	Viral RNAIBA 02/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 02/2021 - 01/2020
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021 - 01/2021
2	Linezolid (Zyvox)FDA Link 01/2016 - 01/2015
1	ceftazidime drug combination avibactamIBA 08/2023
1	Tigecycline (Tygacil)FDA Link 08/2023
1	Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric 07/2023
1	Minocycline (Cyclops)FDA LinkGeneric 07/2023
1	Amoxicillin (Wymox)FDA LinkGeneric 07/2023
1	carbapenemaseIBA 01/2023
1	AzolesIBA 08/2022
1	LactamsIBA 01/2022
1	Penicillin-Binding Proteins (Penicillin-Binding Protein)IBA 01/2022
1	Cystatin CIBA 12/2021
1	CreatineIBA 12/2021
1	AlbuminsIBA 02/2021
1	fibrin fragment D (D-dimer)IBA 02/2021
1	ProteomeIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	EpitopesIBA 01/2021
1	PhosphatidylserinesIBA 12/2020
1	EnzymesIBA 12/2020
1	Glycoproteins (Glycoprotein)IBA 12/2020
1	Immunoglobulin A (IgA)IBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Immunoglobulin M (IgM)IBA 12/2020
1	ImmunosorbentsIBA 12/2020
1	Nucleic AcidsIBA 12/2020
1	Prothrombin (Factor II)IBA 12/2020
1	Anticardiolipin AntibodiesIBA 12/2020
1	Factor VIII (Coagulation Factor VIII)IBA 10/2020
1	AnticoagulantsIBA 10/2020
1	CoagulantsIBA 10/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 03/2019
1	Vancomycin FDA LinkGeneric 01/2016
1	Daptomycin FDA Link 06/2015
1	entecavir FDA Link 09/2014
1	Tenofovir (Viread)FDA Link 09/2014
1	adefovir dipivoxil (Hepsera)FDA Link 09/2014
1	Lamivudine (Epivir)FDA Link 09/2014
1	adefovirIBA 09/2014
1	lipoarabinomannan (LAM)IBA 09/2014
1	VaccinesIBA 07/2011
1	Flucytosine (Ancobon)FDA Link 08/2002
1	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2002
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2002

Therapy/Procedure

8	Therapeutics 08/2023 - 08/2002
1	Personal Protective Equipment 02/2021